Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Seroquel
Pharma
AstraZeneca escapes 1 of 2 Seroquel pay-for-delay claims
A federal judge said a $107 million value isn't sufficiently "large" or "justified" to sustain an antitrust claim for Seroquel XR.
Angus Liu
Jul 8, 2022 11:58am
AZ sells U.S., Canada Seroquel rights to Cheplapharm for $42M
Dec 3, 2019 12:22pm
AstraZeneca's rummage sale continues with second deal in a week
Nov 6, 2018 10:08am
AZ shells out $110M to wrap up Seroquel, Crestor marketing suits
Aug 8, 2018 10:35am
FiercePharmaAsia—Takeda-Shire, HKEX and more
May 11, 2018 9:55am
AstraZeneca revives yard-sale strategy with Seroquel rights sale
May 8, 2018 12:29pm
